XML 85 R54.htm IDEA: XBRL DOCUMENT v3.24.2
Shareholders' Equity (Narrative) (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
May 29, 2024
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Increase (decrease) in stock-based compensation from change in management's estimate       $ 1,238  
Unrecognized compensation cost   $ 98,909   98,909  
Total intrinsic value of options exercised       21,230  
Aggregate intrinsic value of options exercisable   $ 52,518   $ 52,518  
Market value of Company's common stock (in USD per share)   $ 64.69   $ 64.69  
Weighted average exercise price per share (in USD per share)   $ 55.79   $ 55.79  
Total options outstanding (in shares)   15,621   15,621  
Total options exercisable (in shares)   5,471   5,471  
Dividends declared per common share (in USD per share) $ 0.46 $ 0.46 $ 0.43 $ 0.46 $ 0.43
Cash dividends declared   $ 60,285 $ 57,177 $ 60,285 $ 57,177
Common Stock Buyback          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Shares purchased and retired (in shares)       2,456  
Company purchased, cost       $ 167,163  
Remaining stock repurchase authorization amount   $ 114,914   $ 114,914  
2014 Plan | Tranche One          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Vesting rate       50.00%  
2014 Plan | Tranche Two          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Vesting rate       50.00%  
Minimum          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Award waiting period       2 years  
Maximum          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Award waiting period       4 years